Browsing tag:

semi-solid


As the global population ages, we’ll see an increase in the demand for SSDs or topical drugs. And as drug companies innovate, the semi-solid dose will fill needs that other forms cannot.

  For decades, the most popular form of drug dosage has consistently remained oral solids —the tablet, the pill, the capsule. This trend is likely to continue, but the oral solid’s unassuming younger sibling – the semi-solid dose (SSD) – is making some noise. The semi-solids market is growing, and will continue to grow, over[…]

Read More

LGM Helps Pharma Manage Supply Chain Risks with Added Services Through Nexgen Acquisition

COVID-19 has put supply chain risk management practices under the microscope. Coming on the heels of many other, more localized supply issues in the last decade, it has brought about a near-global assessment that supply chains need to be more tightly controlled and redundant – and less dependent on external, at-risk suppliers. In a sense,[…]

Read More

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service